Linnaeus Therapeutics Awarded Up to $22 Million from ARPA-H to Advance its Lead Drug Candidate for Healthspan Preservation
Linnaeus will use these funds to further develop LNS880.
PCI Showcases Precision Medicine During the JP Morgan Healthcare Conference
PCI hosted its annual Innovation @ Penn program at Wharton San Francisco.
Penn, BioNTech SE and Osage University Partners (OUP) Launch $50 Million Penn-BioNTech Innovative Therapeutics Seed Fund
The dedicated venture capital fund will invest in early-stage life science companies spun out of Penn.
Penn I-Corps Fall 2025 Cohort Completes Program
Ten teams completed the program, and 26 individuals received valuable training in entrepreneurship.
Washington Post Article Highlights Bayh-Dole’s Role in U.S. Innovation
The article discusses how nearly all significant modern medicines originated from taxpayer-funded university research.
Thermo Fisher Scientific Opens Philadelphia-Based Collaboration Center
The newly expanded 53,000-square-foot biotech incubator, the Philadelphia ATxCC aims to provide emerging startups and biopharma organizations with resources and tech.
Eli Lilly Announces Opening of Lilly Gateway Labs Site in Philadelphia
The facility, which will support six to eight biotech startups, is set to open next year.
Penn Leaders Share Penn’s Approach to the Rapidly Changing Research Landscape
The article details Penn’s focus on sustaining research excellence, strengthening collaboration, and reshaping the University’s research enterprise to further expand its impact.
Penn Expands its Immunology Research
Penn’s newly developed seven-story facility at 3600 Civic Center Boulevard will bring together labs across disciplines to advance breakthroughs in immune health, autoimmunity, and infectious diseases.
Penn Signs Cooperative AI Advising Agreement with the Commonwealth of Pennsylvania
The University of Pennsylvania and Pennsylvania Governor Josh Shapiro’s Office of Administration signed a cooperative agreement.